Literature summary for 3.2.1.117 extracted from

Masat, E; Lafor�t, P; De Antonio, M; Corre, G; Perniconi, B; Taouagh, N; Mariampillai, K; Amelin, D; Mauhin, W; Hogrel, JY; Caillaud, C; Ronzitti, G; Puzzo, F; Kuranda, K; Colella, P; Mallone, R; Benveniste, O; Mingozzi, F; ,
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients. (2016), Sci Rep, 6, 36182.

Organism

Organism	UniProt	Comment	Textmining

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)